Biogen cuts price of Alzheimer’s drug Aduhelm in half – UPI.com

The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022.
— Read on www.upi.com/Health_News/2021/12/21/Biogen-Alzheimers-drug-Aduhelm/3011640035706/